TNF-α Enhances the Therapeutic Effects of MenSC-Derived Small Extracellular Vesicles on Inflammatory Bowel Disease through Macrophage Polarization by miR-24-3p
暂无分享,去创建一个
Qi Zhang | C. Xiang | Li Yuan | Yifei Li | Lijun Chen | Xin Chen | Jiamin Fu | Yangxin Fang | Zhenyu Xu | Huikang Xu | Sining Zhou | Qi Zhang
[1] E. Candi,et al. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases , 2022, Signal Transduction and Targeted Therapy.
[2] D. Bokov,et al. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells. , 2022, International immunopharmacology.
[3] F. Sánchez-Margallo,et al. IFN-Gamma and TNF-Alpha as a Priming Strategy to Enhance the Immunomodulatory Capacity of Secretomes from Menstrual Blood-Derived Stromal Cells , 2021, International journal of molecular sciences.
[4] Jun Liu,et al. Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases , 2021, Frontiers in Immunology.
[5] Pingdong Jia,et al. Irf1- and Egr1-activated transcription plays a key role in macrophage polarization: A multiomics sequencing study with partial validation. , 2021, International immunopharmacology.
[6] C. Xiang,et al. Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine , 2021, Stem Cell Research & Therapy.
[7] Xiaolan Zhang,et al. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6 , 2021, Stem cell research & therapy.
[8] M. Neurath,et al. Role of the IL23/IL17 Pathway in Crohn’s Disease , 2021, Frontiers in Immunology.
[9] S. Hashemi,et al. Adipose‐derived mesenchymal stem cell‐secreted exosome alleviates dextran sulfate sodium‐induced acute colitis by Treg cell induction and inflammatory cytokine reduction , 2021, Journal of cellular physiology.
[10] R. Xu,et al. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial , 2021, Signal Transduction and Targeted Therapy.
[11] T. Taketomi,et al. Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss , 2020, Acta biomaterialia.
[12] C. Xiang,et al. Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases , 2020, World journal of stem cells.
[13] C. Xiang,et al. Human menstrual blood-derived stem cells mitigate bleomycin-induced pulmonary fibrosis through anti-apoptosis and anti-inflammatory effects , 2020, Stem Cell Research & Therapy.
[14] T. Ye,et al. AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization , 2020, Theranostics.
[15] D. Xie,et al. Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway , 2020, Stem Cell Research & Therapy.
[16] Qiang Zhao,et al. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization , 2020, Theranostics.
[17] Zhiwei Xu,et al. HucMSC‐exosomes carrying miR‐326 inhibit neddylation to relieve inflammatory bowel disease in mice , 2020, Clinical and translational medicine.
[18] Jiafeng Lin,et al. Exosomes derived from umbilical cord mesenchymal stem cells alleviate viral myocarditis through activating AMPK/mTOR‐mediated autophagy flux pathway , 2020, Journal of cellular and molecular medicine.
[19] Y. Zou,et al. Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis , 2020, Stem Cell Research & Therapy.
[20] L. Peyrin-Biroulet,et al. Positioning therapies in ulcerative colitis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[21] A. Arsenijević,et al. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma , 2019, Stem cells international.
[22] Xiaowen He,et al. Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. , 2019, JCI insight.
[23] Yue Zhou,et al. The MSC-Derived Exosomal lncRNA H19 Promotes Wound Healing in Diabetic Foot Ulcers by Upregulating PTEN via MicroRNA-152-3p , 2019, Molecular therapy. Nucleic acids.
[24] Jilong Shen,et al. Toxoplasma ROP16I/III ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages , 2019, World journal of gastroenterology.
[25] C. Xiang,et al. Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases , 2019, Stem Cell Research & Therapy.
[26] J. Cui,et al. Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways , 2019, Cell.
[27] J. Mehta,et al. Sustained Delivery System for Stem Cell-Derived Exosomes , 2019, Front. Pharmacol..
[28] J. S. Heo,et al. Adipose-Derived Mesenchymal Stem Cells Promote M2 Macrophage Phenotype through Exosomes , 2019, Stem cells international.
[29] P. He,et al. Exosomes Derived From M2b Macrophages Attenuate DSS-Induced Colitis , 2019, Front. Immunol..
[30] S. Vermeire,et al. Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling , 2019, Gut.
[31] Zhiwei Dong,et al. MSC-Derived Exosome Promotes M2 Polarization and Enhances Cutaneous Wound Healing , 2019, Stem cells international.
[32] G. Matteoli,et al. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD , 2019, Nature Reviews Gastroenterology & Hepatology.
[33] C. Xiang,et al. Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements , 2019, Stem Cell Research & Therapy.
[34] H. Ji,et al. YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial Homeostasis. , 2019, Cell reports.
[35] S. Lim,et al. MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. , 2019, Biomaterials.
[36] Xuan Sun,et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization , 2019, Cardiovascular research.
[37] C. Xiang,et al. The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine , 2019, Stem Cell Research & Therapy.
[38] A. Ivens,et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis , 2018, Front. Immunol..
[39] Jing Xu,et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.
[40] Yongmin Yan,et al. Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. , 2018, ACS nano.
[41] C. Shao,et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases , 2018, Nature Reviews Nephrology.
[42] Y. Takakura,et al. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application. , 2018, Biological & pharmaceutical bulletin.
[43] L. Öhman,et al. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies , 2018, Scandinavian journal of gastroenterology.
[44] S. Lim,et al. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. , 2018, Biomaterials.
[45] S. Neelamegham,et al. The microRNA regulatory landscape of MSC-derived exosomes: a systems view , 2018, Scientific Reports.
[46] Nima Hamidi,et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.
[47] A. Orekhov,et al. The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2. , 2018, Immunobiology.
[48] M. Ericsson,et al. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation , 2018, American journal of respiratory and critical care medicine.
[49] C. Dörfer,et al. IL-1/TNF-α Inflammatory and Anti-Inflammatory Synchronization Affects Gingival Stem/Progenitor Cells' Regenerative Attributes , 2017, Stem Cells International.
[50] D. Prockop,et al. Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus , 2017, Proceedings of the National Academy of Sciences.
[51] M. Pittenger,et al. Concise Review: MSC‐Derived Exosomes for Cell‐Free Therapy , 2017, Stem cells.
[52] A. Gasbarrini,et al. Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future , 2017, Expert review of clinical immunology.
[53] R. Owens,et al. Oncostatin M drives intestinal inflammation in mice and its abundance predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease , 2017, Nature Medicine.
[54] M. Chopp,et al. MicroRNA-17–92 Cluster in Exosomes Enhance Neuroplasticity and Functional Recovery After Stroke in Rats , 2017, Stroke.
[55] C. Xiang,et al. Human Menstrual Blood‐Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators , 2016, Stem cells translational medicine.
[56] C. Xiang,et al. Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure , 2017, Stem Cell Research & Therapy.
[57] J. Schaefer. MicroRNAs: how many in inflammatory bowel disease? , 2016, Current opinion in gastroenterology.
[58] P. Gros,et al. The macrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammation , 2016, The Journal of experimental medicine.
[59] Suk-Kyun Yang. Personalizing IBD Therapy: The Asian Perspective , 2016, Digestive Diseases.
[60] G. Kaplan,et al. The global burden of IBD: from 2015 to 2025 , 2015, Nature Reviews Gastroenterology &Hepatology.
[61] S. Rutella,et al. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine. , 2015, Gastroenterology.
[62] Xiaoming Fan,et al. The pathological role of microRNAs and inflammation in colon carcinogenesis. , 2015, Clinics and research in hepatology and gastroenterology.
[63] T. Anchordoquy,et al. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[64] M. Cottone,et al. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. , 2014, World journal of gastroenterology.
[65] C. Xiang,et al. Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous progenitor differentiation in type 1 diabetic mice. , 2014, Stem cells and development.
[66] Markus F. Neurath,et al. Cytokines in inflammatory bowel disease , 2014, Nature Reviews Immunology.
[67] T. Ritter,et al. Concise review: Adult mesenchymal stromal cell therapy for inflammatory diseases: How well are we joining the dots? , 2013, Stem cells.
[68] Dan Knights,et al. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome , 2013, Gut.
[69] S. O'Dea,et al. IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro. , 2013, Stem cells and development.
[70] N. Kosaka,et al. The therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles , 2013, Proteomics.
[71] Francisco Guarner,et al. The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.
[72] Fiona Powrie,et al. Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.
[73] Hao Wang,et al. Endometrial regenerative cells: A novel stem cell population , 2007, Journal of Translational Medicine.
[74] P. Mannon,et al. The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.
[75] Alberto Mantovani,et al. Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.
[76] J. Ingwall,et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.
[77] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[78] Thomas D. Schmittgen,et al. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .